Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-05-09

Clinical Trial Update: Alogliptin Tablets Special Drug Use Surveillance: Mild Type 2 Diabetes Mellitus

View source ↗

Summary

Clinical trial update for alogliptin tablets under special surveillance in mild type 2 diabetes mellitus; study completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alogliptin tablets (alogliptin)

Snippet

Sponsor: Takeda | Conditions: Type 2 Diabetes Mellitus | Status: COMPLETED | Results posted: 2019-05-09